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A20 is a tumor necrosis factor (TNF)-inducible zinc finger protein that contains both ubiquitinating and deubiquitinating activities. A20
negatively regulates NFκB (nuclear factor κB) signaling induced by TNF receptor family and Toll-like receptors, but the mechanism of A20 action
is poorly defined. Here we show that a fraction of endogenous and ectopically expressed A20 is localized to an endocytic membrane compartment
that is in association with the lysosome. The lysosomal association of A20 requires its carboxy terminal zinc finger domains, but is independent of
its ubiquitin-modifying activities. Interestingly, A20 mutants defective in membrane association also contain reduced NFκB inhibitory activity.
These findings suggest the involvement of a lysosome-associated mechanism in A20-dependent termination of NFκB signaling.
Published by Elsevier B.V.Keywords: A20; Lysosomal degradation; Ubiquitin; NFκB; Deubiquitinating enzyme1. Introduction
Members of the tumor necrosis factor receptor (TNFR) family
mediate cellular responses to various environmental stimuli such as
inflammation, septic shock, viral infection, and apoptotic signals
[1–3]. The binding of TNF and its related cytokines to their
corresponding receptors induces oligomerization of the receptor
and subsequent activation of various signaling pathways that
include nuclear factor κB (NFκB), Jun N-terminal kinase, p38,
extracellular signal-related kinase (ERK) and class 1 phosphoino-
sitide 3-kinase (PI3K) [4]. One of the best studied pathways is the
activation of NFκB by TNF receptor 1 (TNFR-I). Activation of
TNFR-I induces the assembly of a receptor-associated complex.
This complex comprises the adaptor protein TRADD (TNF re-
ceptor-associated death domain), the Ser/Thr protein kinase RIP1⁎ Corresponding author. Building 5, Room 433, Laboratory of Molecular
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doi:10.1016/j.bbamcr.2008.01.029(receptor interacting protein), and a TRAF (TNF receptor-asso-
ciated factor) domain-containing protein termed TRAF2 [5–10].
The formation of this complex triggers a series of intracellular
events that lead to the activation of the transcription factor NFκB.
TNFR-I also activates JNKkinase through TRAF2, resulting in the
activation of another transcription factor c-Jun [11–14].
TNFR-I mediated NFκB activation is tightly controlled by
both positive and negative regulatory circuits. The zinc finger
protein A20 is a potent inhibitor of TNFR-I-mediated NFκB
signaling [15]. Intriguingly, the expression of A20 is upregulated
upon NFκB activation [16], which then promotes the termination
of NFκB signaling [17–23]. Thus, A20 is part of a negative
regulatory feedback loop that restrains NFκB activation. As
expected, lack of A20-dependent regulatory circuit leads to
prolonged NFκB activation, which causes sustained inflamma-
tory responses and cachexia as revealed in mice deficient for A20
[23]. The expression of A20 is also upregulated by IL-1, lipo-
polysaccharide, and by the activation of the B cell surface receptor
CD40 [15,24]. Thus, the NFκB inhibitory function of A20 may
not be limited to the TNF pathway. Indeed, recent studies showed
that A20 can also downregulate NFκB signal induced by Toll-like
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signaling events is not well understood. It was recently shown that
A20 can inhibit TNFR-I dependent NFκB signaling by regulating
the stability of RIP1. During this process, A20 functions as a dual
ubiquitin-modifying enzyme; it first acts as a deubiquitinating
enzyme [26–29]. The deubiquitinating activity harbored in A20′s
amino-terminal OTU (ovarian tumor) domain removes Lys63-
linked ubiquitin chains from RIP1. Subsequently, A20 functions
as a ubiquitin ligase to assemble Lys48-linked ubiquitin chains
on RIP1 using its carboxy terminal zinc finger domains, which
triggers the proteasome dependent degradation of RIP1 [27].
Likewise, it was shown that A20 can also deubiquitinate TRAF6,
a key signaling molecule required for Toll-like receptor-induced
NFκB signaling [25].
Although the downregulation of RIP1 by A20 can to some
extent explain the inhibitory effect of A20 on TNFR-I induced
NFκB signaling [30], A20 mutants lacking ubiquitin-modifying
activities due to lesions in either the OTU or the zinc finger
domains can still inhibit NFκB signaling under some circum-
stances [21,26,31,32]. This suggests the existence of a ubiquitin
independent mechanism for A20 function in certain cellular con-
texts. To explore the potential additionalmechanism employed by
A20 to downregulate NFκB signaling, we characterize the sub-
cellular localization of A20 using both confocal microscopy and
biochemical fraction approaches. Strikingly, our data reveal that a
fraction of A20 protein is localized to a lysosome-associated
membrane compartment. The association of A20 with the lyso-
some raises the possibility that A20 may downregulate certain
signaling molecules required for sustained NFκB activation by
targeting them for degradation in the lysosome.
2. Materials and methods
2.1. Constructs, antibodies, chemicals and cell lines
The pRK-Flag-A20 wt and pRK-HA-A20 wt plasmids were described
previously [21,24,33]. The pEYFP-A20 plasmid was constructed by ligating the
PCR amplified A20 coding sequence into the BglII and SalI sites of the pEYFP-
C1 vector (Clontech). The insert was shuttled to other pEXFP-C1 vectors to
create plasmids expressing A20 tagged with other fluorescent proteins.
Constructs expressing A20 variants were generated by site directed mutagenesis
following the conventional protocol. Flag, Myc, and A20 (59A426) monoclonal
antibodies were purchased from Sigma, Roche, and Imagenex, respectively.
LAMP1 antibody (H5G11) was purchased from Santa Cruz. Myc–ubiquitin, E1,
and GST–Ubc7 were purchased from Boston Biochem Inc. Lysotraker and
FM4-64 were purchased from Invitrogen. 293T, COS7, and HeLa cells were
purchased from ATCC and maintained according to standard protocols.
2.2. Transfection, immunoblotting, and luciferase experiments
Transfection was done with Polyfect (Qiagen) for COS7 cells, the TransIT293
reagent (Mirus) for 293Tcells, Lipofectamine2000 (Invitrogen) forMEF cells, and
HeLa Monster (Mirus) for HeLa cells. Immunoblotting was performed according
to standard protocols. All experiments were repeated at least once, and
representative images of gels are shown. NFκB luciferase reporter experiments
were performed as previously described [33].
2.3. Subcellular fractionation and membrane floatation experiments
Cells were lysed in a hypotonic buffer (50 mM Hepes, 7.3, 10 mM potassium
chloride, 2 mMmagnesium chloride, 1 mMdithiothreitol, plus a protease inhibitorcocktail) by passing through 25G needles and by subsequent homogenization in a
Dounce homogenizer. Cell extracts were cleared by centrifugation at 1000 ×g to
remove the nuclei and intact cells. The supernatant fractions were subjected to
further centrifugation at 100,000 ×g to separate the membrane pellets from the
cytosol. To float the lysosome-associated membranes, microsomes were resus-
pended in a buffer M (50 mM Hepes, 7.3, 150 mM potassium acetate, 2 mM
magnesium chloride) that also contains 67% sucrose. Membranes (50 µl) were
placed at the bottom of an ultracentrifugation tube under a layer of 130 µl buffer M
containing 40% sucrose and a layer of 20 µl buffer M containing 20% sucrose.
Membranes were subjected to centrifugation in a Beckman TLA100.1 rotor at
200 kg for 1 h. Fractions (20 µl) were taken and analyzed by immunoblotting.
2.4. In vitro ubiquitination experiment
293T cells transfected with plasmids expressing either A20 or A20 Znf4C2
were lysed in NP40 lysis buffer (50 mM Tris–HCl, pH 8.0, 150 mM sodium
chloride, 0.5%NP40, 5 mMmagnesium chloride and a protease inhibitor cocktail).
A20 was immunopurified using Flag antibody bound to the protein G beads. The
immunoprecipitates were subjected to in vitro ubiquitination reaction according to
previously described protocol [34]. Briefly, Myc–ubiquitin (25 µM), E1 (60 nM),
GST–Ubc7 (200 nM) were added to A20 immunoprecipitates, and the reaction
was incubated at 37 °C in a buffer containing 25 mM Tris–HCl, pH 7.4, 2 mM
magnesium/ATP, and0.1mMDTTfor 1 h. The ubiquitination reactionwas stopped
by addition of SDS sample buffer. Samples were analyzed by immunoblotting.
2.5. Immunostaining and live cell imaging
Immunofluorescence experiments were performed as described previously
[35]. Briefly, cells fixed in a phosphor saline solution (PBS) containing 4%
paraformaldehyde were permeabilized in a solution containing 0.1% NP40 and
4% normal donkey serum. Cells were then stained with primary and secondary
antibodies in the same buffer. Unless specified in the figure legends, the
following antibody dilutions were used. A20, 1:250; Flag, 1:1000. To stain the
lysosome, Lysotracker was used at 500 nM. To label the endocytic compartment,
cells were incubated in a buffer containing 95 mM sodium chloride, 50 mM
potassium chloride, 10 mM glucose, 10 mM Hepes 7.4, 1.2 mM calcium
chloride, 1.2 mMmagnesium chloride, 5 µg/ml FM4-64 at room temperature for
4 min. Cells were imaged using either a Zeiss Axiovert fluorescence microscope
or a Zeiss LSM 510 laser scanning confocal microscope equipped with a 63× oil
immersion Plan-Apochromat objective (N/A 1.4). For 3-D deconvolution, we
used the fast reiterative algorithm provided in the Axiovision 4.5 software. For
live cell imaging, cells grown in LabTek chambers were transfected with
plasmids expressing the indicated proteins, and imaged using an inverted Zeiss
LSM 510 confocal microscope. For high speed multi-channel imaging, the
interlace mode was used to simultaneously capture signals from multiple
fluophores.
3. Results
3.1. Membrane association of A20
To dissect the mechanism by which A20 inhibits NFκB sig-
naling, we first examined the subcellular localization of endog-
enous A20 by immunostaining with an A20 specific monoclonal
antibody. To our surprise, A20 did not display diffuse cytoplasmic
staining as might be expected from its being a soluble protein.
Instead, a fraction of A20 appeared to associate with certain
membrane vesicles that were localized near the nuclei in HeLa
cells (Fig. 1A, panel b; Fig. 1B, panel a). The punctate perinuclear
staining of A20 was also seen in a pancreatic tumor cell line
(AR42J) (Fig. 1B, panel c), andwasmore apparent in cells treated
with TNFα (Fig. 1A, panel c; Fig. 1B, panels b, d). This staining
pattern was not observed in cells stained with a control antibody
(Fig. 1A, panel a).
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biochemical fractionation experiments. To this end, HeLa cells
were lysed in a hypotonic buffer that lacked detergent. Post-
nuclear fractions of the cell extract were subjected to further
centrifugation at 100,000 ×g. The resulting pellet fraction
(P100) contained the total membranes, and supernatant fraction
(S100) contained the cytosol. Immunoblotting showed that a
small fraction of endogenous A20 was present in the membrane
fraction, and as expected, when HeLa cells were exposed to
TNFα, the expression of A20 was upregulated, and the level of
membrane-associated A20 was also increased (Fig. 1C).We next expressed epitope-tagged A20 in COS7 cells.
Similar to endogenous A20, Flag-A20 was localized to the
cytosol and to small vesicles that were enriched in a juxtanuclear
region in most A20 expressing cells (Fig. 1A, panel d). In a
fraction of cells, larger A20-containing vesicles were formed
(Fig. 1A, panels e, f), likely due to higher levels of A20
expression. CFP- or YFP-tagged A20 (CFP-A20/YFP-A20) was
similarly localized in many bright speckles near the nuclei
(Fig. 2). These vesicles appeared to contain CFP-A20 both in the
membranes and in the lumen, although the luminal CFP-A20
could not be stained by a GFP antibody, presumably because the
lumen of these compartments was inaccessible to antibodies
when cells were permeabilized by a mild detergent NP40 during
immunostaining (Fig. 2A). Consistent with this interpretation,
previous work demonstrated that a significant fraction of A20
cannot be extracted by NP40 lysis buffer [36].
We next performed FRAP (fluorescence recovery after pho-
tobleaching) experiments using YFP-A20 to determine the dy-
namics of A20-membrane association. Because of the highly
mobile nature of the vesicles, we performed photobleaching on
larger more stationary YFP-A20-containing structures. Shortly
after the removal of the YFP-A20 signal by photobleaching, a
rapid recovery of the signal was observed (Fig. 2B). Since the
recovery of YFP-A20 signal was similarly observed in cells
treated with nocodazole, a microtubule disrupting drug (Fig. 2C),
which inhibited the movement and thus the fusion of A20-
containing vesicles, the recovery of YFP-A20 signal after
photobleaching most likely occurs by recruitment of YFP-A20
from a nearby cytosolic pool rather than by fusion of other A20-
containing vesicleswith the photobleachedmembranes. Together,
these data demonstrate that a fraction of both endogenously and
ectopically expressed A20 is dynamically associated with an
intracellular membrane compartment localized near the nuclei.
3.2. Localization of A20 to a lysosome-associated endocytic
compartment
To determine the precise localization of A20, we performed
co-immunofluorescence experiments using markers for variousFig. 1. A20 is localized to an intracellular membrane compartment. (A) (a–c)
Subcellular localization of endogenous A20 in HeLa cells. HeLa cells treated with
TNFα (80 ng/ml, 6 h) or non-treated were stained with either an A20 specific
monoclonal antibody (αA20) or control IgG. Arrows indicate the perinuclear
enrichment of A20-containing vesicles. Same exposure times were used for these
images. (d–f) COS7 cells expressing Flag-tagged wild type A20 were stained with
an anti-Flag antibody (αFlag). Images represent cells with A20-containing vesicles
of different size. (B) Membrane association of endogenous A20. HeLa cells (a, b)
or AR42J cells (c, d) treated with TNFα or non-treated were stained with an anti-
A20 monoclonal antibody at the indicated concentration. The bottom panels also
show the nuclei stained by DAPI in blue. Images were obtained with a Zeiss
Axiovert fluorescence microscope equipped with a 63× oil immersion Plan-
Apochromat objective (N/A 1.4). (C) Biochemical fractionation experiment. HeLa
cells untreated (−TNFα) or treated with TNFα (+TNFα) were lysed, fractionated,
and analyzed by immunoblotting with antibodies to either A20, the lysosomal
membrane protein LAMP1, or the cytosolic protein E1. Note that the loading of the
supernatant fraction is equivalent to ~30% of the pellet fraction. The small amount
of LAMP1 in S100 fractions was likely due to incomplete fractionation.
Fig. 2. Dynamic association of A20with membrane. (A)Membrane association of
CFP-tagged A20. COS7 cells transfected with a CFP-A20 expressing constructs
were stained with an anti-GFP antibody (in red), which also recognized the CFP
tag. The cells were also imaged using a band pass filter specific for CFP (in green).
The insets show an enlarged view of a vesicle indicated by the arrow. (B) FRAP
experiment demonstrates the dynamic association of A20 with membranes. A
small area (indicated by the boxes) in a COS7 cell expressingYFP-taggedA20was
targeted with a high intensity laser light to photobleach the YFP-A20 signal. The
recovery of the fluorescent signal was monitored by time-lapse confocal
microscopy. (C) Quantification of the FRAP experiments as in B.Where indicated,
cells were first treated with nocodazole (10 µg/ml) for 10 min before
photobleaching.
Fig. 3. Localization of A20 to an endocytic compartment. (A) A20 is not
localized to either the ER or Golgi. COS7 cells expressing CFP-tagged A20
together with YFP-tagged markers for either the ER or Golgi were imaged.
(B) Localization of A20 to an endocytic compartment. COS7 cells expressing
GFP-A20 were stained with FM4-64 and imaged. Shown are images of two A20
expressing cells stained with FM4-64.
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was not localized in the ER or Golgi (Fig. 3A). In contrast, when
COS7 cells expressing GFP-A20 were stained with FM4-64, a
dye that labeled all endocytic compartments, A20-containingvesicles were colocalized precisely with a fraction of the FM4-64
positive vesicles (Fig. 3B). Since A20-containing vesicles did not
show significant colocalization with early endosomes that were
positive for EEA1 staining (Li, L. and Ye, Y., unpublished data),
A20 was likely localized to an endocytic compartment that
represented late endosomes. Consistent with this, many A20-
containing vesicles appeared to be tethered to vesicles that could
be stained with Lysotracker, a lysosome specific dye (Fig. 4A,
panels a–c), resulting in partial overlapping of the two
compartments. This was detected in all XY sections of cells
by laser scanning confocal microscopy. The interaction
between the lysosome and A20-containing vesicles was also
observed for endogenous A20, as A20-positive vesicles and the
lysosome were co-enriched in a perinuclear region in HeLa cells
(Fig. 4A, d–f).
To further assess the interaction between A20-containing
vesicles and the lysosome, we used time-lapse confocal micros-
copy to monitor the movement of these two compartments in
cells in real time. The experiments showed that the two com-
partments apparently communicated in some fashion as many
A20-containing vesicles co-migrated with lysosomes over long
Fig. 4. Interaction of A20-containing vesicles with the lysosome. (A) (a–c) Colocalization of GFP-A20 with the lysosome. COS7 cells expressing GFP-tagged A20
(green) were stained with Lysotracker (red). Images were obtained with a laser scanning confocal microscope. The smaller panels show vertical sections along the XZ
and YZ axes indicated by the lines. Arrows highlight some examples of A20-containing vesicles that are either colocalized or tethered with the lysosome. (d–f) Partial
colocalization of endogenous A20 with the lysosome. HeLa cells treated with TNFα for 6 h were stained with an anti-A20 antibody (green) and Lysotracker (Lyso,
red). Shown is a deconvoluted horizontal section obtained with an Axiovert fluorescence microscope. (B) Co-migration of A20-containing vesicles with the lysosomal
vesicles. COS7 cells expressing GFP-tagged A20 were stained with Lysotracker, and imaged in real time by a laser scanning confocal microscope in the interlace mode
(see online supplemental material for the movies). Shown are three examples representing A20 vesicles of different size. Arrows highlight some examples of A20-
containing structures (green) that interact with the lysosome (red). Arrowheads in the top panels indicate one example of an A20 vesicle that co-migrates with a
lysosome. Asterisks in the bottom panels indicate a lysosomal vesicle that is being targeted to an A20-containing membrane compartment. N, nuclei.
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that some A20-containing vesicles appeared to fuse with the
associated lysosomal vesicles after interacting with them for
prolonged periods of time, resulting in transient overlap of the
two signals.
3.3. Lysosome-associated localization of A20 requires its
carboxy terminal zinc fingers
To understand howA20 interacts with membranes, we studied
the localization of several A20 mutants using both imaging andbiochemical fractionation approaches. We first generated A20
mutants that lacked either the last two (A20 1–696) or the last
four zinc finger domains (A20 1–560) and expressed them in
HeLa cells as CFP fusion proteins. Unlike wild type A20, these
mutants were mostly localized to the cytosol (Fig. 5A).
Fractionation experiments revealed an increase in the level of
these zinc finger-deleted A20 mutants in the cytosolic fraction
with a compensatory decrease in the membrane fraction when
compared with wild type A20 (Fig. 5B, lanes 7, 8 vs. lane 6). We
next used a membrane floatation assay to further assess the
membrane association of A20. To this end, microsomes isolated
Fig. 5. Membrane association of A20 involves its carboxy terminal zinc finger domains. (A) The membrane localization of A20 requires its carboxy terminal zinc
finger domains. Shown are HeLa cells expressing the indicated CFP-tagged A20 variants (green). Nuclei were counter-stained with DAPI (blue). (B) 293T cells
transfected with a GFP expressing plasmid together with constructs expressing the indicated A20 variants were lysed in a hypotonic buffer and fractionated as
described in the materials and methods. The proteins in the membrane pellet fraction (P100) and the cytosol (S100) were analyzed by immunoblotting (IB) with the
indicated antibodies. Note that the loading of the supernatant fraction is equivalent to ~10% of the pellet fraction. (C) Scheme of the membrane floatation experiment
shown in (D). (D) Membrane association of A20 variants examined by a membrane floatation assay. Fractions were analyzed by immunoblotting (IB) with antibodies
to the indicated proteins.
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buffer containing a high concentration of sucrose. The mem-
branes were placed underneath two layers of solutions that each
contained a different concentration of sucrose (Fig. 5C).When the
sample was subjected to centrifugation, a sucrose gradient formed
and membrane vesicles migrated within the gradient to reach aposition according to their density [37]. Indeed, many LAMP1
containing lysosomal vesicles were able to float to various levels,
which might reflect their heterogeneity in density. A fraction of
wild type A20 also floated in a similar fashion. In contrast, the
bulk of the rough ER membranes remained at the bottom of the
gradient due to the binding of ribosomes (Fig. 5D, top panels).
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microsomes is indeed a result of its association with membranes.
Because not all lysosomal vesicles were able to float, it was
difficult to accurately measure the relative amount of lysosome-
associated A20 for different A20 variants in this experiment.
Nonetheless, the defect in membrane association for A20 1–560
was obvious as little A20 1–560 was detected in the floated
fractions (Fig. 5D). A fraction of A20 1–696 was found in
association with membranes (Fig. 5D). However, because cells
expressing A20 1–696 contained fewer A20 speckles as judged
by immunofluorescence experiment, we conclude that the abilityFig. 6. Inhibition of TNFα-mediated NFκB activation by A20 variants. (A) Schem
mutations. (OTU, ovarian tumor; NZF, Npl4 zinc finger) (B) Expression of A20 var
(C) NFκB inhibiting activity of A20 variants in 293T cells. Luciferase activity in
together with the indicated A20 variants were measured and normalized by the level o
the A20 variants in primary embryonic fibroblast cells. The inset shows the expressio
A20 requires the last zinc finger domain. HeLa cells expressing the indicated Flag
counter-stained with DAPI (blue).of A20 1–696 to associate with the lysosome is dramatically
inhibited.
Since a previous study showed that the action of A20 in
NFκB signaling involved its OTU domain-dependent deubiqui-
tinating function as well as its ubiquitin ligase activity, we
determined whether the membrane association of A20 required
these ubiquitin-modifying activities. We mutated the two con-
served cysteine residues in the fourth zinc finger motif of A20.
The resulting mutant (A20 Znf4C2) was defective in assembly
of ubiquitin chains (Fig. S1A). We also generated a deubiqui-
tinating defective A20 mutant (A20 C103A) according to theatic representation of the A20 constructs. Arrows indicate the position of point
iants in 293T cells. A GFP expressing construct was co-transfected as a control.
extracts of TNFα-stimulated 293T cells expressing a NFκB luciferase reporter
f co-expressed GFP. Error bars show s.d. (n=6). (D) NFκB inhibiting activity of
n of the A20 variants. Error bars show s.d. (n=3). (E) Membrane localization of
-tagged A20 variants were stained with anti-Flag antibody (red). Nuclei were
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their ability to associate with membranes, a significant portion of
these proteins were detected in the membrane pellet similar to
wild type A20 (Fig. S1B). Immunofluorescence experiments
also revealed that these mutants were able to associate with the
perinuclear vesicles (data not shown). Collectively, these results
indicate that the lysosome association of A20 is independent of
its ubiquitin-modifying activities.
3.4. NFκB inhibiting activity of A20 mutants
We next analyzed the NFκB inhibitory activity of various
A20mutants. Interestingly, A20mutants lacking either ubiquitin
ligase (Znf4C2) or deubiquitinating activities (C103A) were as
effective as wild type A20 in terminating TNFα induced NFκB
signaling as indicated by a NFκB luciferase reporter assay. On
the other hand, A20 mutants defective in membrane association
(A20 1–696 and A20 1–560) exhibited reduced activity in
downregulating NFκB signaling in both 293T and primary
mouse embryonic fibroblast cells (MEF) (Fig. 6). These findings
indicate that the membrane association of A20 but not the
ubiquitin-modifying activity may be critical for the NFκB in-
hibitory function of A20 at least under the condition of A20
overexpression. This conclusion is in full agreement with pre-
vious findings that A20 mutants lacking domains (either the
OTU or the fourth zinc finger domain) essential for its ubiquitin-
modifying activities are as active as wild type A20 in a similar
NFκB reporter assay [21,26,31,32], and that the deletion of the
last zinc finger domain is associated with significant loss in A20
activity [31].
To further reconcile our findings with the published data, we
generated an additional A20 mutant that lacked solely the last
zinc finger (A20 1–744). Immunofluorescence experiment dem-
onstrated that A20 1–744 was indeed defective in membrane
association because few A20 containing vesicles were observed
in cells expressing this mutant (Fig. 6E). Functionally, the A20
1–744 mutant exhibited a small but statistically significant de-
crease in NFκB inhibitory activity when compared to wild type
A20 (Fig. 6C, D). Moreover, further deletion of additional A20
zinc finger domains was associated with a progressive loss in
A20 activity, consistent with a previous report [31]. It should
be noted that since zinc finger-deleted A20 mutants were
consistently expressed at higher levels than wild type A20
(Fig. 6B, D), their inhibitory activity may be overestimated in
these luciferase reporter experiments. Consistent with this
notion, a similar set of A20 mutants generated by Natoli et al.
was reported to be more severely impeded in their function in
HeLa cells. It is conceivable that experimental designs including
the cell line and method used to achieve A20 overexpression
may affect the level of membrane association for a given A20
mutant, which may lead to different degree of loss-of-function
under various experimental conditions. In support of this view,
membrane floatation experiments showed that a fraction of the
A20 1–744 mutant was indeed bound to membranes similar to
A20 1–696 in 293T cells (data not shown). Together, the data
show that deletion of the last zinc finger of A20 concurrently
reduces its membrane association and its NFκB inhibitoryactivity. We therefore conclude that the A20-mediated NFκB
inhibitory function may involve a membrane-associated process
under certain conditions.
4. Discussion
In this study, we demonstrate that a fraction of A20 is asso-
ciated with an endocytic compartment that communicates with
the lysosome. First, immunofluorescence experiments reveal
that a fraction of endogenous and ectopically expressed A20 is
colocalized with FM4-64 positive vesicles near the nuclei. These
vesicles exhibit partial colocalization with the lysosome.
Second, biochemical fractionation experiments further confirm
the localization of a fraction of A20 in a membrane compart-
ment. Finally, dynamic interaction between A20-containing
vesicles and lysosomes is observed by time-lapse confocal
microscopy.
We further show that the membrane association of A20
requires its carboxy terminal zinc finger domains, but is inde-
pendent of its ubiquitin-modifying activities. Intriguingly, we find
that A20 mutants defective in membrane association also contain
reduced NFκB inhibiting activities in both 293T and primary
mouse embryonic fibroblast cells. These observations indicate
that lysosome-associated A20 may participate in regulation of
NFκB signaling under certain conditions.
A previous report showed that A20 can target RIP1 for
degradation by the proteasome to inhibit NFκB activity in amouse
MEF cell line. This process requires both the ubiquitin ligase and
deubiquitinating activities of A20 [27]. However, we find that
these ubiquitin-modifying activities of A20 are dispensable for the
NFκB inhibitory function in several cell lines tested under the
condition of A20 overexpression. Our findings fully agree with
several other reports, which demonstrated that A20 mutants
lacking the ubiquitin-modifying functions still possess significant
NFκB inhibitory activity inmany types of cells [21,26,31,32]. The
luciferase reporter assays used in these studies are similar, but the
cell line and method chosen to achieve A20 expression are dif-
ferent, which may account for the above mentioned discrepancy.
These distinct observations made under various experimental
conditions seem to suggest that A20 may be able to operate by at
least two independent mechanisms, and a ubiquitin independent
process can contribute to A20-regulated NFκB signaling, which
likely involves the lysosomes at least under certain experimental
conditions.
How lysosome-associated A20 regulates NFκB signaling is
currently unknown. One attractive idea is that A20 may target
certain signaling molecules to the lysosome for degradation,
which may lead to termination of NFκB signaling. In support of
this view, a recent study demonstrated that the termination of Toll-
like receptor-induced NFκB signaling involves Rab7b, a GTPase
that is also localized to a lysosome-associated compartment
similar to A20 [38]. We have investigated a few candidates
including RIP1 and TRAF2 since previous studies suggested that
these proteins interact with A20 [21,27]. However, our data
suggest that the endogenous level of both RIP1 and TRAF2 are
not significantly downregulated in cells under the condition of
either TNFα stimulation or A20 overexpression (data not shown),
1148 L. Li et al. / Biochimica et Biophysica Acta 1783 (2008) 1140–1149which is consistent with previous reports [27,39]. Thus, a com-
plete survey of signaling molecules of NFκB pathway is required
to identify potential A20 substrates that may undergo lysosome
dependent degradation upon TNFR activation.
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